Experimental Treatments for Azoospermia

An honest look at varicocele repair, PRP, stem cells, isotretinoin, and why most don't work.

Last updated: May 2026 Reading time: ~5 min Step: 10 of 14

Key Takeaways

Most experimental treatments lack solid evidence for azoospermia today.
Most NOA cases are genetic, and PRP / stem cells / exosomes don't fix genetic defects.
Varicocele repair for azoospermia is theoretical — varicoceles are common in fertile men too.
In-vitro gametogenesis (IVG) — making sperm from skin or blood cells — has worked in mice and is the most promising future option for men with no sperm at all. Not yet available in humans.
Don't let experimental treatments delay proven steps like extended sperm searches and microTESE.

In-Vitro Gametogenesis (IVG): Sperm From Skin Cells

In-vitro gametogenesis, or IVG, is the process of taking an ordinary somatic cell — typically a skin or blood cell — reprogramming it into an induced pluripotent stem cell (iPSC), and then coaxing that stem cell to differentiate all the way into a functional sperm or egg in a laboratory dish. If it works in humans, it would be the first treatment that could give biological children to men who have no sperm anywhere in their body, including men with complete AZFa or AZFb deletions, Sertoli-cell-only syndrome, or other conditions where surgical retrieval cannot succeed.

What's already been done

2011 (mice): Dr. Mitinori Saitou's group at Kyoto University produced functional sperm from mouse iPSCs and used them to father healthy, fertile pups.
2016 (mice): Dr. Katsuhiko Hayashi's lab generated the entire egg cycle from mouse skin cells, producing live offspring that were themselves fertile.
2018–present (humans): Multiple labs have produced early-stage human germ-cell precursors (primordial germ cell-like cells, or PGCLCs) from human iPSCs. Getting those to mature all the way into functional human sperm is the remaining hard problem.
2023: Hayashi's group reported producing functional sperm from female mice (XX cells), demonstrating same-sex reproduction in mammals — a striking proof of how flexible the technology may become.

Who is working on it

This is no longer just academic. Several well-funded biotech companies are actively trying to translate IVG to humans, including Conception Biosciences (initially focused on eggs but with broader gametogenesis work), Gameto, and Ivy Natal. Academic groups in Japan (Saitou, Hayashi), the UK, and the US are all racing on the underlying science.

Realistic timeline

No serious researcher in the field will give a date. Estimates from people actually doing the work generally fall in the range of 5 to 15+ years before clinical use, and "first human IVG baby" is likely to happen well before "IVG is a routinely available clinical treatment for azoospermia." There are major remaining hurdles: getting human germ cells to fully mature in vitro, making sure they're genetically and epigenetically normal, regulatory approval, and figuring out who pays for it.

Why this matters specifically for azoospermia For most azoospermic men, modern surgical retrieval (especially microTESE) plus IVF/ICSI already works — sperm exists somewhere in the testicle and can be found. IVG is most relevant for the smaller group where no sperm exists anywhere: complete AZFa/AZFb microdeletions, Sertoli-cell-only syndrome with no foci of spermatogenesis, or men who have been through unsuccessful microTESE attempts. For those men, IVG is currently the only foreseeable path to a biological child without using donor sperm.

What to do with this information today: Almost certainly nothing clinical — IVG is not available, not in clinical trials for male infertility, and not something to wait for at the expense of pursuing surgery, extended sperm searches, or other proven options. But it's worth knowing the field is moving, and worth following if your situation is one where current options have been exhausted.

Varicocele Repair

Varicocele repair involves surgically removing enlarged blood vessels (varicoceles) in the testicle. Some theorize this procedure may help azoospermic patients either regain sperm in their ejaculate or achieve better surgical outcomes during sperm retrieval.

The problem with this theory: It's very difficult to understand how varicoceles — which are extremely common in fertile men — would actually cause azoospermia. The available data is not conclusive, making varicocele repair an experimental treatment for azoospermia at best.

Realistic expectations: Varicocele repair likely doesn't work for azoospermia, and if it does have any effect, it's probably very minor.

PRP, Stem Cell, and Exosome Injections

These treatments are extremely theoretical, with potentially some (though highly debatable) scientific basis. These approaches are essentially experimental ideas and should not be generally considered viable treatment options.

For the desperate If you're someone willing to try anything and potentially invest in unproven treatments, you could consider one of these options — but understand you may be purchasing ineffective therapy. Make sure you've completed the proven steps (extended search, hormone optimization, microTESE) first.

Isotretinoin

Retinoic Acid Pathway and Spermatogenesis

Isotretinoin is a synthetic retinoid that affects retinoic acid signaling, which plays a crucial role in spermatogenesis. Retinoic acid is essential for the initiation of meiosis in spermatogonia and the proper differentiation of germ cells. In NOA, there's often disrupted spermatogenesis, and isotretinoin may help restore normal retinoic acid signaling pathways that support sperm production.

There is evidence suggesting retinoic acid may be produced during spermatogenesis rather than being strictly necessary for its initiation. Some research indicates that retinoic acid production may be a consequence of normal spermatogenic activity and the spermatogenesis + retinoic acid relationship may be more of a feedback loop rather than a simple requirement.

Why All Experimental Treatments Likely Don't Work

Understanding the biology of non-obstructive azoospermia explains why these experimental approaches are problematic:

Two Main Categories of NOA

Rare cases: Men who have no sperm stem cells whatsoever (which would normally develop into sperm)

Most cases: Men who have stem cells that stop progressing during the sperm development process. This arrest is typically genetic — specific genes cause the sperm production process to halt partway through. In some less common instances, supporting environment issues within the testicle, specifically Sertoli cell dysfunction, can interfere with sperm development.

The Logic Problem

Given that most non-obstructive azoospermia cases are fundamentally genetic, it's difficult to reason how PRP, stem cell injections, or exosome treatments would address the underlying genetic causes preventing sperm development. These treatments don't correct genetic defects or restore missing cellular machinery needed for sperm production.

Making Informed Decisions

While the desire to try any possible treatment is understandable, it's important to recognize that these experimental approaches:

Lack strong scientific evidence for effectiveness
May be expensive with no insurance coverage
Could delay more established treatment options
May not address the root genetic causes of azoospermia

Before considering experimental treatments, ensure you've fully explored proven diagnostic and treatment options, including extended sperm searches and consultation with experienced fertility specialists.

← Previous: IVF Process Next: Considering Donor Conception →